178 related articles for article (PubMed ID: 36319940)
21. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
22. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
Liang W; He J; Shen Y; Shen J; He Q; Zhang J; Jiang G; Wang Q; Liu L; Gao S; Liu D; Wang Z; Zhu Z; Ng CS; Liu CC; Petersen RH; Rocco G; D'Amico T; Brunelli A; Chen H; Zhi X; Liu B; Yang Y; Chen W; Zhou Q; He J
J Clin Oncol; 2017 Apr; 35(11):1162-1170. PubMed ID: 28029318
[TBL] [Abstract][Full Text] [Related]
23. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics.
Chiappetta M; Sperduti I; Ciavarella LP; Leuzzi G; Bria E; Mucilli F; Lococo F; Filosso P; Ratto G; Spaggiari L; Facciolo F; Margaritora S
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):315-323. PubMed ID: 32747930
[TBL] [Abstract][Full Text] [Related]
24. Impact of the number of examined lymph nodes on stage migration in node-negative gastric cancer patients: a Chinese multi-institutional analysis with propensity score matching.
Gu P; Deng J; Wang W; Wang Z; Zhou Z; Xu H; Liang H
Ann Transl Med; 2020 Aug; 8(15):938. PubMed ID: 32953738
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
Kneuertz PJ; Kamel MK; Stiles BM; Lee BE; Rahouma M; Harrison SW; Altorki NK; Port JL
Ann Thorac Surg; 2018 Oct; 106(4):981-988. PubMed ID: 29908980
[TBL] [Abstract][Full Text] [Related]
26. The minimum number of examined lymph nodes for accurate nodal staging and optimal survival of stage T1-2 esophageal squamous cell carcinoma: A retrospective multicenter cohort with SEER database validation.
Tian D; Li HX; Yang YS; Yan HJ; Jiang KY; Zheng YB; Zong ZD; Zhang HL; Guo XG; Wen HY; Chen LQ
Int J Surg; 2022 Aug; 104():106764. PubMed ID: 35803513
[TBL] [Abstract][Full Text] [Related]
27. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
Yang H; Mei T
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
[TBL] [Abstract][Full Text] [Related]
29. Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.
Brown LM; Cooke DT; Jett JR; David EA
Ann Thorac Surg; 2018 Jan; 105(1):207-213. PubMed ID: 29132704
[TBL] [Abstract][Full Text] [Related]
30. Different prognostic significance of examined lymph node count for patients with non-small-cell lung cancer ≤1 cm or >1-2 cm: a population-based study.
Liang Z; Wang X; Yang H; Fu H; Li M; Feng Z; Peng Z; Wang H
Future Oncol; 2020 Jan; 16(3):4497-4509. PubMed ID: 31845824
[No Abstract] [Full Text] [Related]
31. Prognostic impact of number of examined lymph nodes on survival of patients with appendiceal neuroendocrine tumors.
Du R; Xiao JW
World J Clin Cases; 2022 Oct; 10(30):10906-10920. PubMed ID: 36338239
[TBL] [Abstract][Full Text] [Related]
32. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
Yang H; Li M; Mei T
Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
[TBL] [Abstract][Full Text] [Related]
33. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
[TBL] [Abstract][Full Text] [Related]
34. Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database.
Ernani V; Appiah AK; Rodriguez D; Kusne Y; Beamer SE; Ravanbakhsh S; Jaroszewski D; Reck Dos Santos P; Sio TT; Yu N; Yang P; Schild S; D'Cunha J
Cancer; 2023 Mar; 129(6):860-866. PubMed ID: 36562086
[TBL] [Abstract][Full Text] [Related]
35. Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: A population-based study.
Yong J; Ding B; Dong Y; Yang M
Front Oncol; 2022; 12():994105. PubMed ID: 36203444
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study.
Liu Y; Yang H; Fu H; Li M; Feng Z; Peng Z; Liang Z; Wang H
Thorac Cancer; 2019 Jul; 10(7):1636-1643. PubMed ID: 31237106
[TBL] [Abstract][Full Text] [Related]
37. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.
Chen C; Shen J; Xing Z; Jiang C; Hu L; Cui L; Xue D; He X; Xu R
Int Urol Nephrol; 2020 Feb; 52(2):271-278. PubMed ID: 31571158
[TBL] [Abstract][Full Text] [Related]
38. Sublobar Resection in the Treatment of Peripheral Typical Carcinoid Tumors of the Lung.
Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
Ann Thorac Surg; 2019 Sep; 108(3):859-865. PubMed ID: 31059684
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
[TBL] [Abstract][Full Text] [Related]
40. Optimal examined lymph node number for accurate staging and long-term survival in rectal cancer: a population-based study.
Guan X; Jiao S; Wen R; Yu G; Liu J; Miao D; Wei R; Zhang W; Hao L; Zhou L; Lou Z; Liu S; Zhao E; Wang G; Zhang W; Wang X
Int J Surg; 2023 Aug; 109(8):2241-2248. PubMed ID: 37428195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
